WallStreetZenWallStreetZen

NASDAQ: TERN
Terns Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Terns Pharmaceuticals earnings were -$96.2M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest TERN earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$23.6M, down 4.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, TERN reported annual earnings of -$96.2M, with 8.3% growth.

TERN earnings history

Current Revenue
$0.0
Current Earnings
-$96.2M
Current Profit Margin
0%

TERN Return on Equity

Current Company
-20%
Current Industry
-31.4%
Current Market
28.9%
TERN's Return on Equity (-20%)... subscribe to Premium to read more.
High Return on Equity Performance

TERN Return on Assets

Current Company
-19.4%
Current Industry
-9.6%
TERN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when TERN announces earnings.

TERN Return on Capital Employed

Current Company
-9.48%
Current Industry
-3.7%
TERN has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TERN vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
TERN-$95.13M-$96.21MN/A-$1.03
PTCT-$14.06M-$186.73MN/A-$2.48
CNTA-$237.11M-$250.64MN/A-$1.79
BLTE-$77.15M-$77.61MN/A-$2.31
COGT-$345.43M-$354.30MN/A-$2.17
View Top Biotech Stocks

Terns Pharmaceuticals Earnings Reports & History FAQ

What were Terns Pharmaceuticals's earnings last quarter?

On TERN's earnings call on Invalid Date, Terns Pharmaceuticals (NASDAQ: TERN) reported Q4 2025 earnings per share (EPS) of -$0.24, up 4.35% year over year. Total TERN earnings for the quarter were -$23.57 million. In the same quarter last year, Terns Pharmaceuticals's earnings per share (EPS) was -$0.23.

If you're new to stock investing, here's how to buy Terns Pharmaceuticals stock.

Is Terns Pharmaceuticals profitable or losing money?

As of the last Terns Pharmaceuticals earnings report, Terns Pharmaceuticals is currently losing money. Terns Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$96.21 million, a 8.28% increase year over year.

What was TERN's earnings growth in the past year?

As of Terns Pharmaceuticals's earnings date in Invalid Date, Terns Pharmaceuticals's earnings has grown year over year. TERN earnings in the past year totalled -$96.21 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.